About 100 reports

  • Clinical Trial profile. 63 Trial Title
  • Clinical Trial profile. 113 Trial Title

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) clinical...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • United States
  • Market Size

The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/ IND, pre registration, phase ##, phase ##, and phase ## trials).

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pathology
  • Pharmaceutical

GASTROINTESTINAL (GI) DISORDERS ##. ##. ##.

  • Gastrointestinal Drug
  • North America
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC

Constipation is a common functional gastrointestinal (GI) disorder that is most prevalent in the elderly and female population.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • Pharmaceutical
  • 10.2 ABBREVIATIONS
  • 2.1 CATALYST

The usage of opioids and their adverse effects in gastrointestinal practice: a review.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Ltd.
  • DIGESTIVE REMEDIES IN RUSSIA - CATEGORY ANALYSIS

Doctors also significantly contributed to the growth of microgranules by prescribing them to people with gastrointestinal problems.

  • Gastrointestinal Drug
  • OTC
  • Russia
  • Demand
  • Consumer Lifestyles Fuel Demand for Digestive Remedies

Stress can cause and exacerbate numerous digestive disorders, including nausea, indigestion and heartburn, as well as general gastrointestinal upset.

  • Gastrointestinal Drug
  • OTC
  • United States
  • Demand

Moreover, vitamins and dietary supplements must not be advertised for any specific medicinal purpose, such as cardiovascular or gastrointestinal disease.

  • Gastrointestinal Drug
  • OTC
  • Singapore
  • Demand

Zentiva' s key product groups include anti-infection products and medicines for cardiovascular disease, pain, central nervous system disorders, female healthcare and gastrointestinal diseases.

  • Gastrointestinal Drug
  • Sleep Aid
  • Romania
  • Demand
  • Zentiva NV

By Clinical Trial Stages: The report provides Gastrointestinal Disorders pipeline molecules by clinical trial stages including both early and late stage development - phase ## clinical trials, phase ## clinical trials, phase ## clinical trials, preclinical research, and discovery stag

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.
  • CLINICAL TRIAL PROFILE SNAPSHOTS
  • Clinical Trial Product Information

PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO

  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited
  • TRENDS

In addition, stressful and fast-paced lifestyles, with tight schedules and traffic jams, impact the digestive system, causing tension, which is reflected in gastrointestinal discomfort.

  • Gastrointestinal Drug
  • OTC
  • Colombia
  • Demand
  • Tecnoquímicas SA
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF INFECTIOUS DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS
  • PROPORTION OF INFECTIOUS DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2017*

Infectious Diarrhea Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H2, 2017" provides an overview of Infectious Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Infectious...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World
  • Product Initiative
  • Target
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Clinical Trial profile. 38 Trial Title

## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## Epworth HealthCare Dianthus Medical Limited (Inactive) ## ## ## ## ## ## ## ## Cook Medical Inc Source: GlobalData' s Pharma Intelligence Center

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 5 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Takeda Pharmaceutical Company Limited
  • Clinical Trial profile. 303 Trial Title
  • Clinical Trial profile. 465 Trial Title

Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2018" provides an overview of Post Operative Nausea And Vomiting clinical trials scenario.This report provides...

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • Clinical Trial profile. 255 Trial Title
  • Clinical Trial profile. 137 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Merck & Co., Inc.
  • Clinical Trial profile. 17 Trial Title
  • Target

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 99 Trial Title
  • Clinical Trial profile. 108 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • About the Phase III GUARD study
  • APR 19, 2017: REDHILL BIOPHARMA TO HOST R&D DAY ON BEKINDA FOR ACUTE GASTROENTERITIS AND IBS-D

IBS IS ONE OF THE MOST COMMON GASTROINTESTINAL DISORDERS.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • RedHill Biopharma Ltd.
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%),
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux...

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • NANOTHERAPEUTICS INC
  • FEATURED NEWS & PRESS RELEASES

IBS is one of the most common gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • RedHill Biopharma Ltd.
  • NARONAPRIDE - DRUG PROFILE
  • MAR 23, 2016: IRONWOOD PHARMACEUTICALS INITIATES PHASE IIB CLINICAL TRIAL OF IW-3718 IN REFRACTORY GASTRO ESOPHAGEAL REFLUX DISEASE

Patients were randomly assigned to one of two arms - one arm received Insegia alone, the other arm received placebo.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Clinical Trial profile. 103 Trial Title
  • Clinical Trial profile. 301 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • AstraZeneca PLC
  • Opportunity - Market Potential - Gastrointestinal Disorders
  • Opportunity - Strong Product Pipeline

Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company
  • Ferring International Center S.A.
  • ASTRAZENECA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH IRONWOOD PHARMA FOR LINACLOTIDE
  • PARTNERSHIPS

Linaclotide Delayed Release-## (DR##).

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company Financials
  • Ironwood Pharmaceuticals, Inc.
  • Official Title
  • Official Title

Dyspepsia Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Dyspepsia Global Clinical Trials Review, H2, 2017" provides an overview of Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspepsia. Report includes an overview of...

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World